Chemours
474 hedge funds and large institutions have $3.24B invested in Chemours in 2022 Q4 according to their latest regulatory filings, with 68 funds opening new positions, 102 increasing their positions, 189 reducing their positions, and 74 closing their positions.
19% more capital invested
Capital invested by funds: $2.72B → $3.24B (+$518M)
0.5% more ownership
Funds ownership: 71.11% → 71.62% (+0.5%)
8% less first-time investments, than exits
New positions opened: 68 | Existing positions closed: 74
3% less funds holding
Funds holding: 487 → 474 (-13)
16% less call options, than puts
Call options by funds: $63.2M | Put options by funds: $75.4M
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
46% less repeat investments, than reductions
Existing positions increased: 102 | Existing positions reduced: 189
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$60.4M |
| 2 |
JP Morgan Chase
New York
|
+$35.2M |
| 3 |
Pacer Advisors
Malvern,
Pennsylvania
|
+$23M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$20.3M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$16.7M |
Top Sellers
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$32.9M |
| 2 |
Balyasny Asset Management
Chicago,
Illinois
|
-$25.2M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$23.2M |
| 4 |
AWAM
Appian Way Asset Management
New York
|
-$19M |
| 5 |
Prudential Financial
Newark,
New Jersey
|
-$17.3M |
CC Hedge Fund Activity: Q4 2022 in Review
474 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Chemours (CC) for Q4 2022, worth a combined $3.24B — up 19% from $2.72B a quarter earlier.
Sellers outnumbered buyers: 74 funds closed out of CC and 68 opened new positions — a net loss of 6 holders — while 189 trimmed existing stakes and 102 added.
The largest buyer was Fidelity Investments, adding an estimated $60.4M. The largest seller was Bank of America, cutting an estimated $32.9M.
- 474 institutional investors held Chemours (CC) as of Q4 2022, down from 487 in Q3 2022.
- Funds reported $3.24B of Chemours stock for Q4 2022, up 19% quarter-over-quarter.
- 68 funds opened new Chemours positions in Q4 2022 and 74 closed out, a net change of -6 holders.
- The largest Chemours buyer in Q4 2022 was Fidelity Investments, an estimated $60.4M added.
- The largest Chemours seller in Q4 2022 was Bank of America, an estimated $32.9M sold.
Based on aggregated 13F filings for Q4 2022.